These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8765973)

  • 1. Autoimmunity and thyroid growth. Where do we stand?
    Drexhage HA
    Eur J Endocrinol; 1996 Jul; 135(1):39-45. PubMed ID: 8765973
    [No Abstract]   [Full Text] [Related]  

  • 2. [The immune and nonimmune genesis of goiter].
    Grigorie D
    Endocrinologie; 1990; 28(3-4):95-106. PubMed ID: 1983320
    [No Abstract]   [Full Text] [Related]  

  • 3. Metamorphic thyroid autoimmunity.
    Ludgate M; Emerson CH
    Thyroid; 2008 Oct; 18(10):1035-7. PubMed ID: 18844474
    [No Abstract]   [Full Text] [Related]  

  • 4. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.
    Chiovato L; Santini F; Vitti P; Bendinelli G; Pinchera A
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):803-6. PubMed ID: 8033373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin receptor autoantibodies induce human thyroid cell growth and c-fos activation.
    Huber GK; Safirstein R; Neufeld D; Davies TF
    J Clin Endocrinol Metab; 1991 May; 72(5):1142-7. PubMed ID: 1850754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulins affecting thyroid growth: a continuing controversy.
    Brown RS
    J Clin Endocrinol Metab; 1995 May; 80(5):1506-8. PubMed ID: 7744993
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.
    Wilson R; McKillop JH; Pearson C; Burnett AK; Gunn I; McNicol AM; Thomson JA
    Clin Exp Immunol; 1988 Aug; 73(2):265-8. PubMed ID: 3263232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HLA-DR antigens by thyroid cells: the effect of Graves' IgG.
    Bodolay E; Szegedi G; Suranyi P; Juhasz F; Stenszky V; Balazs C; Farid NR
    Immunol Lett; 1987 May; 15(1):77-81. PubMed ID: 3111991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
    van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
    Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune mechanisms in Graves' disease.
    Burman KD; Baker JR
    Endocr Rev; 1985; 6(2):183-232. PubMed ID: 2988930
    [No Abstract]   [Full Text] [Related]  

  • 11. The thyrotropin receptor and the regulation of thyrocyte function and growth.
    Vassart G; Dumont JE
    Endocr Rev; 1992 Aug; 13(3):596-611. PubMed ID: 1425489
    [No Abstract]   [Full Text] [Related]  

  • 12. Signaling pathways involved in thyroid hyperfunction and growth in Graves' disease.
    Di Cerbo A; Corda D
    Biochimie; 1999 May; 81(5):415-24. PubMed ID: 10403170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid autoimmunity and thyroid autonomy.
    Vitti P; Mariotti S; Marcocci C; Chiovato L; Giachetti M; Fenzi G; Pinchera A
    Acta Med Austriaca; 1990; 17 Suppl 1():90-2. PubMed ID: 2202187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell recognition of residue 158-176 in thyrotropin receptor confers risk for development of thyroid autoimmunity in siblings in a family with Graves' disease.
    Soliman M; Kaplan E; Guimaraes V; Yanagawa T; DeGroot LJ
    Thyroid; 1996 Dec; 6(6):545-51. PubMed ID: 9001188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antireceptor or antihormone autoimmunity and its relationship with the idiotype network.
    Bach JF
    Adv Nephrol Necker Hosp; 1987; 16():251-80. PubMed ID: 3028089
    [No Abstract]   [Full Text] [Related]  

  • 16. [Basedow disease occurring after allogeneic bone marrow transplantation for acute lymphoblastic leukemia].
    Sasaki Y; Ito K
    Rinsho Ketsueki; 2002 Sep; 43(9):833-5. PubMed ID: 12412287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.
    Chen CR; Pichurin P; Nagayama Y; Latrofa F; Rapoport B; McLachlan SM
    J Clin Invest; 2003 Jun; 111(12):1897-904. PubMed ID: 12813025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune thyrotoxicosis: diagnostic challenges.
    Ponto KA; Kahaly GJ
    Am J Med; 2012 Sep; 125(9):S1. PubMed ID: 22938935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of pathophysiology of Graves' disease by animal models].
    Akamizu T
    Nihon Rinsho Meneki Gakkai Kaishi; 2003 Dec; 26(6):329-35. PubMed ID: 14752933
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of Graves' disease from asymptomatic autoimmune thyroiditis: a case report.
    Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Hama Y; Maruyama M; Amano J
    Endocr J; 1996 Dec; 43(6):743-6. PubMed ID: 9075617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.